{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T23:50:07Z","timestamp":1725493807871},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,1,14]],"date-time":"2011-01-14T00:00:00Z","timestamp":1294963200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s12640-011-9238-y","type":"journal-article","created":{"date-parts":[[2011,1,13]],"date-time":"2011-01-13T19:03:06Z","timestamp":1294945386000},"page":"250-262","source":"Crossref","is-referenced-by-count":16,"title":["The Effect of Docosahexaenoic Acid on Visual Evoked Potentials in a Mouse Model of Parkinson\u2019s Disease: The Role of Cyclooxygenase-2 and Nuclear Factor Kappa-B"],"prefix":"10.1007","volume":"20","author":[{"given":"Ozlem","family":"Ozsoy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gamze","family":"Tanriover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narin","family":"Derin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nimet","family":"Uysal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Necdet","family":"Demir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burcu","family":"Gemici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ceren","family":"Kencebay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piraye","family":"Yargicoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aysel","family":"Agar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mutay","family":"Aslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,1,14]]},"reference":[{"key":"9238_CR1","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0093-7754(01)90034-X","volume":"28","author":"J Adams","year":"2001","unstructured":"Adams J (2001) Proteasome inhibition in cancer: development of PS-341. Semin Oncol 28:613\u2013619","journal-title":"Semin Oncol"},{"key":"9238_CR2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0924-977X(01)00077-3","volume":"11","author":"T Araki","year":"2001","unstructured":"Araki T, Mizutani H, Matsubara M, Imai Y, Mizugaki M, Itoyama Y (2001) Nitric oxide synthase inhibitors cause motor deficits in mice. Eur Neuropsychopharmacol 11:125\u2013133","journal-title":"Eur Neuropsychopharmacol"},{"key":"9238_CR3","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0168-5597(94)90057-4","volume":"92","author":"L Barbato","year":"1994","unstructured":"Barbato L, Rinalduzzi S, Laurenti M, Ruggieri S, Accornero N (1994) Color VEPs in Parkinson\u2019s disease. Electroencephalogr Clin Neurophysiol 92:169\u2013172","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"9238_CR4","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1017\/S0317167100026147","volume":"14","author":"A Barbeau","year":"1987","unstructured":"Barbeau A, Roy M, Bernier G, Campanella G, Paris S (1987) Ecogenetics of Parkinson\u2019s disease: prevalence and environmental aspects in rural areas. Can J Neurol Sci 14:36\u201341","journal-title":"Can J Neurol Sci"},{"key":"9238_CR5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.plefa.2009.05.024","volume":"81","author":"NG Bazan","year":"2009","unstructured":"Bazan NG (2009) Cellular and molecular events mediated by docosahexaenoic acid-derived neuroprotectin D1 signaling in photoreceptor cell survival and brain protection. Prostaglandins Leukot Essent Fatty Acids 81:205\u2013211","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"9238_CR6","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/35072550","volume":"2","author":"MF Beal","year":"2001","unstructured":"Beal MF (2001) Experimental models of Parkinson\u2019s disease. Nat Rev Neurosci 2:325\u2013334","journal-title":"Nat Rev Neurosci"},{"key":"9238_CR7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","volume":"20","author":"H Bernheimer","year":"1973","unstructured":"Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1973) Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 20:415\u2013455","journal-title":"J Neurol Sci"},{"key":"9238_CR8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/155005949702800305","volume":"28","author":"I Bodis-Wollner","year":"1997","unstructured":"Bodis-Wollner I (1997) Visual electrophysiology in Parkinson\u2019s disease: PERG, VEP and visual P300. Clin Electroencephalogr 28:143\u2013147","journal-title":"Clin Electroencephalogr"},{"key":"9238_CR9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1749-6632.1982.tb50800.x","volume":"388","author":"I Bodis-Wollner","year":"1982","unstructured":"Bodis-Wollner I, Onofrj M (1982) System diseases and visual evoked potential diagnosis in neurology: changes due to synaptic malfunction. Ann N Y Acad Sci 388:327\u2013348","journal-title":"Ann N Y Acad Sci"},{"key":"9238_CR10","first-page":"323","volume":"45","author":"I Bodis-Wollner","year":"1987","unstructured":"Bodis-Wollner I, Onofrj M (1987) The visual system in Parkinson\u2019s disease. Adv Neurol 45:323\u2013327","journal-title":"Adv Neurol"},{"key":"9238_CR11","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/brain\/101.4.661","volume":"101","author":"I Bodis-Wollner","year":"1978","unstructured":"Bodis-Wollner I, Yahr MD (1978) Measurements of visual evoked potentials in Parkinson\u2019s disease. Brain 101:661\u2013671","journal-title":"Brain"},{"issue":"Pt 6","key":"9238_CR12","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1093\/brain\/110.6.1675","volume":"110","author":"I Bodis-Wollner","year":"1987","unstructured":"Bodis-Wollner I, Marx MS, Mitra S, Bobak P, Mylin L, Yahr M (1987) Visual dysfunction in Parkinson\u2019s disease. Loss in spatiotemporal contrast sensitivity. Brain 110(Pt 6):1675\u20131698","journal-title":"Brain"},{"key":"9238_CR13","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.neuint.2009.12.022","volume":"56","author":"C Boudrault","year":"2010","unstructured":"Boudrault C, Bazinet RP, Kang JX, Ma DW (2010) Cyclooxygenase-2 and n-6 PUFA are lower and DHA is higher in the cortex of fat-1 mice. Neurochem Int 56:585\u2013589","journal-title":"Neurochem Int"},{"key":"9238_CR14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0952-3278(93)90003-F","volume":"48","author":"JM Bourre","year":"1993","unstructured":"Bourre JM, Bonneil M, Clement M, Dumont O, Durand G, Lafont H, Nalbone G, Piciotti M (1993) Function of dietary polyunsaturated fatty acids in the nervous system. Prostaglandins Leukot Essent Fatty Acids 48:5\u201315","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"9238_CR15","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1096\/fj.07-9677com","volume":"22","author":"M Bousquet","year":"2008","unstructured":"Bousquet M, Saint-Pierre M, Julien C, Salem N Jr, Cicchetti F, Calon F (2008) Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson\u2019s disease. Faseb J 22:1213\u20131225","journal-title":"Faseb J"},{"key":"9238_CR16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.brainres.2007.07.067","volume":"1175","author":"JD Boyd","year":"2007","unstructured":"Boyd JD, Jang H, Shepherd KR, Faherty C, Slack S, Jiao Y, Smeyne RJ (2007) Response to 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) differs in mouse strains and reveals a divergence in JNK signaling and COX-2 induction prior to loss of neurons in the substantia nigra pars compacta. Brain Res 1175:107\u2013116","journal-title":"Brain Res"},{"key":"9238_CR17","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/ana.410220313","volume":"22","author":"C Bulens","year":"1987","unstructured":"Bulens C, Meerwaldt JD, Van der Wildt GJ, Van Deursen JB (1987) Effect of levodopa treatment on contrast sensitivity in Parkinson\u2019s disease. Ann Neurol 22:365\u2013369","journal-title":"Ann Neurol"},{"key":"9238_CR18","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0921-884X(96)95700-8","volume":"100","author":"T Buttner","year":"1996","unstructured":"Buttner T, Kuhn W, Muller T, Heinze T, Puhl C, Przuntek H (1996) Chromatic and achromatic visual evoked potentials in Parkinson\u2019s disease. Electroencephalogr Clin Neurophysiol 100:443\u2013447","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"9238_CR19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s007020050007","volume":"107","author":"T Buttner","year":"2000","unstructured":"Buttner T, Muller T, Kuhn W (2000) Effects of apomorphine on visual functions in Parkinson\u2019s disease. J Neural Transm 107:87\u201394","journal-title":"J Neural Transm"},{"key":"9238_CR20","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.neures.2008.07.005","volume":"62","author":"M Cansev","year":"2008","unstructured":"Cansev M, Ulus IH, Wang L, Maher TJ, Wurtman RJ (2008) Restorative effects of uridine plus docosahexaenoic acid in a rat model of Parkinson\u2019s disease. Neurosci Res 62:206\u2013209","journal-title":"Neurosci Res"},{"key":"9238_CR21","first-page":"4376","volume":"62","author":"PS Carlton","year":"2002","unstructured":"Carlton PS, Gopalakrishnan R, Gupta A, Liston BW, Habib S, Morse MA, Stoner GD (2002) Piroxicam is an ineffective inhibitor of N-nitrosomethylbenzylamine-induced tumorigenesis in the rat esophagus. Cancer Res 62:4376\u20134382","journal-title":"Cancer Res"},{"key":"9238_CR22","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1037\/0735-7044.116.6.1022","volume":"116","author":"J Catalan","year":"2002","unstructured":"Catalan J, Moriguchi T, Slotnick B, Murthy M, Greiner RS, Salem N Jr (2002) Cognitive deficits in docosahexaenoic acid-deficient rats. Behav Neurosci 116:1022\u20131031","journal-title":"Behav Neurosci"},{"key":"9238_CR23","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1038\/sj.cdd.4401963","volume":"13","author":"JE Chipuk","year":"2006","unstructured":"Chipuk JE, Bouchier-Hayes L, Green DR (2006) Mitochondrial outer membrane permeabilization during apoptosis: the innocent bystander scenario. Cell Death Differ 13:1396\u20131402","journal-title":"Cell Death Differ"},{"key":"9238_CR24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0166-2236(98)01299-5","volume":"22","author":"J Cudeiro","year":"1999","unstructured":"Cudeiro J, Rivadulla C (1999) Sight and insight\u2014on the physiological role of nitric oxide in the visual system. Trends Neurosci 22:109\u2013116","journal-title":"Trends Neurosci"},{"key":"9238_CR25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.brainres.2006.05.016","volume":"1101","author":"M Meira Santos Lima de","year":"2006","unstructured":"de Meira Santos Lima M, Braga Reksidler A, Marques Zanata S, Bueno Machado H, Tufik S, Vital MA (2006) Different parkinsonism models produce a time-dependent induction of COX-2 in the substantia nigra of rats. Brain Res 1101:117\u2013125","journal-title":"Brain Res"},{"key":"9238_CR26","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1471-4159.1989.tb09133.x","volume":"52","author":"DT Dexter","year":"1989","unstructured":"Dexter DT, Carter CJ, Wells FR, Javoy-Agid F, Agid Y, Lees A, Jenner P, Marsden CD (1989) Basal lipid peroxidation in substantia nigra is increased in Parkinson\u2019s disease. J Neurochem 52:381\u2013389","journal-title":"J Neurochem"},{"key":"9238_CR27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0006-8993(97)00418-6","volume":"764","author":"KA Disshon","year":"1997","unstructured":"Disshon KA, Dluzen DE (1997) Estrogen as a neuromodulator of MPTP-induced neurotoxicity: effects upon striatal dopamine release. Brain Res 764:9\u201316","journal-title":"Brain Res"},{"key":"9238_CR28","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/0014-4886(81)90092-3","volume":"71","author":"RS Dyer","year":"1981","unstructured":"Dyer RS, Howell WE, MacPhail RC (1981) Dopamine depletion slows retinal transmission. Exp Neurol 71:326\u2013340","journal-title":"Exp Neurol"},{"key":"9238_CR29","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1097\/00001756-200310270-00009","volume":"14","author":"Z Feng","year":"2003","unstructured":"Feng Z, Li D, Fung PC, Pei Z, Ramsden DB, Ho SL (2003) COX-2-deficient mice are less prone to MPTP-neurotoxicity than wild-type mice. Neuroreport 14:1927\u20131929","journal-title":"Neuroreport"},{"key":"9238_CR30","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/BF02531374","volume":"6","author":"C Galli","year":"1971","unstructured":"Galli C, White HB Jr, Paoletti R (1971) Lipid alterations and their reversion in the central nervous system of growing rats deficient in essential fatty acids. Lipids 6:378\u2013387","journal-title":"Lipids"},{"key":"9238_CR31","first-page":"23","volume":"86","author":"T Gasser","year":"2001","unstructured":"Gasser T (2001) Molecular genetics of Parkinson\u2019s disease. Adv Neurol 86:23\u201332","journal-title":"Adv Neurol"},{"key":"9238_CR32","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/jnnp.44.3.227","volume":"44","author":"MJ Gawel","year":"1981","unstructured":"Gawel MJ, Das P, Vincent S, Rose FC (1981) Visual and auditory evoked responses in patients with Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 44:227\u2013232","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9238_CR33","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jss.2009.07.018","volume":"161","author":"B Gemici","year":"2010","unstructured":"Gemici B, Tan R, Ongut G, Izgut-Uysal VN (2010) Expressions of inducible nitric oxide synthase and cyclooxygenase-2 in gastric ischemia-reperfusion: role of angiotensin II. J Surg Res 161:126\u2013133","journal-title":"J Surg Res"},{"key":"9238_CR34","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1007\/BF01291788","volume":"103","author":"M Gerlach","year":"1996","unstructured":"Gerlach M, Riederer P (1996) Animal models of Parkinson\u2019s disease: an empirical comparison with the phenomenology of the disease in man. J Neural Transm 103:987\u20131041","journal-title":"J Neural Transm"},{"key":"9238_CR35","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/j.1471-4159.2006.04061.x","volume":"98","author":"OL German","year":"2006","unstructured":"German OL, Insua MF, Gentili C, Rotstein NP, Politi LE (2006) Docosahexaenoic acid prevents apoptosis of retina photoreceptors by activating the ERK\/MAPK pathway. J Neurochem 98:1507\u20131520","journal-title":"J Neurochem"},{"issue":"Pt 1","key":"9238_CR36","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/brain\/111.1.131","volume":"111","author":"MF Ghilardi","year":"1988","unstructured":"Ghilardi MF, Bodis-Wollner I, Onofrj MC, Marx MS, Glover AA (1988a) Spatial frequency-dependent abnormalities of the pattern electroretinogram and visual evoked potentials in a parkinsonian monkey model. Brain 111(Pt 1):131\u2013149","journal-title":"Brain"},{"key":"9238_CR37","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0024-3205(88)90315-3","volume":"43","author":"MF Ghilardi","year":"1988","unstructured":"Ghilardi MF, Chung E, Bodis-Wollner I, Dvorzniak M, Glover A, Onofrj M (1988b) Systemic 1-methyl,4-phenyl,1-2-3-6-tetrahydropyridine (MPTP) administration decreases retinal dopamine content in primates. Life Sci 43:255\u2013262","journal-title":"Life Sci"},{"key":"9238_CR38","doi-asserted-by":"crossref","first-page":"18754","DOI":"10.1073\/pnas.0704908104","volume":"104","author":"A Ghosh","year":"2007","unstructured":"Ghosh A, Roy A, Liu X, Kordower JH, Mufson EJ, Hartley DM, Ghosh S, Mosley RL, Gendelman HE, Pahan K (2007) Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson\u2019s disease. Proc Natl Acad Sci USA 104:18754\u201318759","journal-title":"Proc Natl Acad Sci USA"},{"key":"9238_CR39","doi-asserted-by":"crossref","first-page":"13543","DOI":"10.1523\/JNEUROSCI.4144-09.2009","volume":"29","author":"A Ghosh","year":"2009","unstructured":"Ghosh A, Roy A, Matras J, Brahmachari S, Gendelman HE, Pahan K (2009) Simvastatin inhibits the activation of p21ras and prevents the loss of dopaminergic neurons in a mouse model of Parkinson\u2019s disease. J Neurosci 29:13543\u201313556","journal-title":"J Neurosci"},{"key":"9238_CR40","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S1388-1981(01)00101-9","volume":"1531","author":"P Green","year":"2001","unstructured":"Green P, Glozman S, Yavin E (2001) Ethyl docosahexaenoate-associated decrease in fetal brain lipid peroxide production is mediated by activation of prostanoid and nitric oxide pathways. Biochim Biophys Acta 1531:156\u2013164","journal-title":"Biochim Biophys Acta"},{"key":"9238_CR41","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1600-0420.2006.00666.x","volume":"84","author":"G Hacioglu","year":"2006","unstructured":"Hacioglu G, Agar A, Yargicoglu P (2006) The role of docosahexaenoic acid on visual evoked potentials in one kidney-one clip hypertension. Acta Ophthalmol Scand 84:488\u2013494","journal-title":"Acta Ophthalmol Scand"},{"key":"9238_CR42","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.nlm.2006.08.001","volume":"87","author":"G Hacioglu","year":"2007","unstructured":"Hacioglu G, Kose O, Aslan M, Agar A (2007) Beneficial effects of docosahexaenoic acid on active avoidance performance in 1K-1C hypertensive rats. Neurobiol Learn Mem 87:159\u2013165","journal-title":"Neurobiol Learn Mem"},{"key":"9238_CR43","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/j.1471-4159.1992.tb10990.x","volume":"59","author":"B Halliwell","year":"1992","unstructured":"Halliwell B (1992) Reactive oxygen species and the central nervous system. J Neurochem 59:1609\u20131623","journal-title":"J Neurochem"},{"key":"9238_CR44","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bbr.2005.04.011","volume":"163","author":"R Haobam","year":"2005","unstructured":"Haobam R, Sindhu KM, Chandra G, Mohanakumar KP (2005) Swim-test as a function of motor impairment in MPTP model of Parkinson\u2019s disease: a comparative study in two mouse strains. Behav Brain Res 163:159\u2013167","journal-title":"Behav Brain Res"},{"key":"9238_CR45","first-page":"2473","volume":"31","author":"C Harnois","year":"1990","unstructured":"Harnois C, Di Paolo T (1990) Decreased dopamine in the retinas of patients with Parkinson\u2019s disease. Invest Ophthalmol Vis Sci 31:2473\u20132475","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9238_CR46","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0013-4694(88)90114-9","volume":"70","author":"BE Hetzler","year":"1988","unstructured":"Hetzler BE, Boyes WK, Creason JP, Dyer RS (1988) Temperature-dependent changes in visual evoked potentials of rats. Electroencephalogr Clin Neurophysiol 70:137\u2013154","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"9238_CR47","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.freeradbiomed.2009.07.013","volume":"47","author":"T Hoang","year":"2009","unstructured":"Hoang T, Choi DK, Nagai M, Wu DC, Nagata T, Prou D, Wilson GL, Vila M, Jackson-Lewis V, Dawson VL, Dawson TM, Chesselet MF, Przedborski S (2009) Neuronal NOS and cyclooxygenase-2 contribute to DNA damage in a mouse model of Parkinson disease. Free Radic Biol Med 47:1049\u20131056","journal-title":"Free Radic Biol Med"},{"key":"9238_CR48","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1073\/pnas.0307453101","volume":"101","author":"S Hunot","year":"2004","unstructured":"Hunot S, Vila M, Teismann P, Davis RJ, Hirsch EC, Przedborski S, Rakic P, Flavell RA (2004) JNK-mediated induction of cyclooxygenase 2 is required for neurodegeneration in a mouse model of Parkinson\u2019s disease. Proc Natl Acad Sci USA 101:665\u2013670","journal-title":"Proc Natl Acad Sci USA"},{"key":"9238_CR49","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s11064-008-9909-0","volume":"34","author":"H Kabuto","year":"2009","unstructured":"Kabuto H, Amakawa M, Mankura M, Yamanushi TT, Mori A (2009) Docosahexaenoic acid ethyl ester enhances 6-hydroxydopamine-induced neuronal damage by induction of lipid peroxidation in mouse striatum. Neurochem Res 34:1299\u20131303","journal-title":"Neurochem Res"},{"key":"9238_CR50","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.brainres.2006.10.089","volume":"1131","author":"JM Kang","year":"2007","unstructured":"Kang JM, Park HJ, Choi YG, Choe IH, Park JH, Kim YS, Lim S (2007) Acupuncture inhibits microglial activation and inflammatory events in the MPTP-induced mouse model. Brain Res 1131:211\u2013219","journal-title":"Brain Res"},{"key":"9238_CR51","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.brainres.2004.09.046","volume":"1030","author":"H Kato","year":"2004","unstructured":"Kato H, Kurosaki R, Oki C, Araki T (2004) Arundic acid, an astrocyte-modulating agent, protects dopaminergic neurons against MPTP neurotoxicity in mice. Brain Res 1030:66\u201373","journal-title":"Brain Res"},{"key":"9238_CR52","first-page":"502","volume":"5","author":"PM Kidd","year":"2000","unstructured":"Kidd PM (2000) Parkinson\u2019s disease as multifactorial oxidative neurodegeneration: implications for integrative management. Altern Med Rev 5:502\u2013529","journal-title":"Altern Med Rev"},{"key":"9238_CR53","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1016\/S0024-3205(97)01007-2","volume":"61","author":"T Kobayashi","year":"1997","unstructured":"Kobayashi T, Araki T, Itoyama Y, Takeshita M, Ohta T, Oshima Y (1997) Effects of L-dopa and bromocriptine on haloperidol-induced motor deficits in mice. Life Sci 61:2529\u20132538","journal-title":"Life Sci"},{"key":"9238_CR54","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/art.1780330607","volume":"33","author":"JM Kremer","year":"1990","unstructured":"Kremer JM, Lawrence DA, Jubiz W, DiGiacomo R, Rynes R, Bartholomew LE, Sherman M (1990) Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. Clinical and immunologic effects. Arthritis Rheum 33:810\u2013820","journal-title":"Arthritis Rheum"},{"key":"9238_CR55","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1388-2457(99)00223-0","volume":"111","author":"T Langheinrich","year":"2000","unstructured":"Langheinrich T, Tebartz van Elst L, Lagreze WA, Bach M, Lucking CH, Greenlee MW (2000) Visual contrast response functions in Parkinson\u2019s disease: evidence from electroretinograms, visually evoked potentials and psychophysics. Clin Neurophysiol 111:66\u201374","journal-title":"Clin Neurophysiol"},{"key":"9238_CR56","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3858\/emm.2009.41.9.069","volume":"41","author":"JA Lee","year":"2009","unstructured":"Lee JA, Song HY, Ju SM, Lee SJ, Kwon HJ, Eum WS, Jang SH, Choi SY, Park JS (2009a) Differential regulation of inducible nitric oxide synthase and cyclooxygenase-2 expression by superoxide dismutase in lipopolysaccharide stimulated RAW 264.7 cells. Exp Mol Med 41:629\u2013637","journal-title":"Exp Mol Med"},{"key":"9238_CR57","doi-asserted-by":"crossref","first-page":"301","DOI":"10.4196\/kjpp.2009.13.4.301","volume":"13","author":"SA Lee","year":"2009","unstructured":"Lee SA, Kim HJ, Chang KC, Baek JC, Park JK, Shin JK, Choi WJ, Lee JH, Paik WY (2009b) DHA and EPA down-regulate COX-2 expression through suppression of NF-kappaB activity in LPS-treated human umbilical vein endothelial cells. Korean J Physiol Pharmacol 13:301\u2013307","journal-title":"Korean J Physiol Pharmacol"},{"key":"9238_CR58","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/jn\/137.1.130","volume":"137","author":"B Levant","year":"2007","unstructured":"Levant B, Ozias MK, Carlson SE (2007) Specific brain regions of female rats are differentially depleted of docosahexaenoic acid by reproductive activity and an (n-3) fatty acid-deficient diet. J Nutr 137:130\u2013134","journal-title":"J Nutr"},{"key":"9238_CR59","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/00019052-200012000-00013","volume":"13","author":"AH Lockwood","year":"2000","unstructured":"Lockwood AH (2000) Pesticides and parkinsonism: is there an etiological link? Curr Opin Neurol 13:687\u2013690","journal-title":"Curr Opin Neurol"},{"key":"9238_CR60","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/01.wnf.0000157066.50948.65","volume":"28","author":"H Matsui","year":"2005","unstructured":"Matsui H, Udaka F, Tamura A, Oda M, Kubori T, Nishinaka K, Kameyama M (2005) The relation between visual hallucinations and visual evoked potential in Parkinson disease. Clin Neuropharmacol 28:79\u201382","journal-title":"Clin Neuropharmacol"},{"key":"9238_CR61","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1046\/j.1471-4159.1995.64041645.x","volume":"64","author":"MB Mattammal","year":"1995","unstructured":"Mattammal MB, Strong R, Lakshmi VM, Chung HD, Stephenson AH (1995) Prostaglandin H synthetase-mediated metabolism of dopamine: implication for Parkinson\u2019s disease. J Neurochem 64:1645\u20131654","journal-title":"J Neurochem"},{"key":"9238_CR62","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/glia.20294","volume":"53","author":"P McLaughlin","year":"2006","unstructured":"McLaughlin P, Zhou Y, Ma T, Liu J, Zhang W, Hong JS, Kovacs M, Zhang J (2006) Proteomic analysis of microglial contribution to mouse strain-dependent dopaminergic neurotoxicity. Glia 53:567\u2013582","journal-title":"Glia"},{"key":"9238_CR63","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.tips.2004.03.003","volume":"25","author":"W Meissner","year":"2004","unstructured":"Meissner W, Hill MP, Tison F, Gross CE, Bezard E (2004) Neuroprotective strategies for Parkinson\u2019s disease: conceptual limits of animal models and clinical trials. Trends Pharmacol Sci 25:249\u2013253","journal-title":"Trends Pharmacol Sci"},{"key":"9238_CR64","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.plefa.2007.10.021","volume":"77","author":"AT Michael-Titus","year":"2007","unstructured":"Michael-Titus AT (2007) Omega-3 fatty acids and neurological injury. Prostaglandins Leukot Essent Fatty Acids 77:295\u2013300","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"9238_CR65","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1471-4159.2008.05249.x","volume":"105","author":"RD Mills","year":"2008","unstructured":"Mills RD, Sim CH, Mok SS, Mulhern TD, Culvenor JG, Cheng HC (2008) Biochemical aspects of the neuroprotective mechanism of PTEN-induced kinase-1 (PINK1). J Neurochem 105:18\u201333","journal-title":"J Neurochem"},{"key":"9238_CR66","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0361-9230(92)90035-V","volume":"28","author":"N Mitra","year":"1992","unstructured":"Mitra N, Mohanakumar KP, Ganguly DK (1992) Dissociation of serotoninergic and dopaminergic components in acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Brain Res Bull 28:355\u2013364","journal-title":"Brain Res Bull"},{"key":"9238_CR67","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1194\/jlr.M100358-JLR200","volume":"43","author":"M Murthy","year":"2002","unstructured":"Murthy M, Hamilton J, Greiner RS, Moriguchi T, Salem N Jr, Kim HY (2002) Differential effects of n-3 fatty acid deficiency on phospholipid molecular species composition in the rat hippocampus. J Lipid Res 43:611\u2013617","journal-title":"J Lipid Res"},{"key":"9238_CR68","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/0024-3205(85)90146-8","volume":"36","author":"WJ Nicklas","year":"1985","unstructured":"Nicklas WJ, Vyas I, Heikkila RE (1985) Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. Life Sci 36:2503\u20132508","journal-title":"Life Sci"},{"issue":"Suppl 1","key":"9238_CR69","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000116351","volume":"26","author":"N Ogawa","year":"1987","unstructured":"Ogawa N, Mizukawa K, Hirose Y, Kajita S, Ohara S, Watanabe Y (1987) MPTP-induced parkinsonian model in mice: biochemistry, pharmacology and behavior. Eur Neurol 26(Suppl 1):16\u201323","journal-title":"Eur Neurol"},{"key":"9238_CR70","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/ana.410110508","volume":"11","author":"M Onofrj","year":"1982","unstructured":"Onofrj M, Bodis-Wollner I (1982) Dopaminergic deficiency causes delayed visual evoked potentials in rats. Ann Neurol 11:484\u2013490","journal-title":"Ann Neurol"},{"key":"9238_CR71","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1136\/jnnp.49.10.1150","volume":"49","author":"M Onofrj","year":"1986","unstructured":"Onofrj M, Ghilardi MF, Basciani M, Gambi D (1986) Visual evoked potentials in parkinsonism and dopamine blockade reveal a stimulus-dependent dopamine function in humans. J Neurol Neurosurg Psychiatry 49:1150\u20131159","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9238_CR72","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1111\/j.1530-0277.2001.tb02187.x","volume":"25","author":"RJ Pawlosky","year":"2001","unstructured":"Pawlosky RJ, Bacher J, Salem N Jr (2001) Ethanol consumption alters electroretinograms and depletes neural tissues of docosahexaenoic acid in rhesus monkeys: nutritional consequences of a low n-3 fatty acid diet. Alcohol Clin Exp Res 25:1758\u20131765","journal-title":"Alcohol Clin Exp Res"},{"key":"9238_CR73","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1023\/A:1024448314608","volume":"107","author":"NS Peachey","year":"2003","unstructured":"Peachey NS, Ball SL (2003) Electrophysiological analysis of visual function in mutant mice. Doc Ophthalmol 107:13\u201336","journal-title":"Doc Ophthalmol"},{"key":"9238_CR74","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1046\/j.1471-4159.2001.00183.x","volume":"76","author":"S Przedborski","year":"2001","unstructured":"Przedborski S, Jackson-Lewis V, Naini AB, Jakowec M, Petzinger G, Miller R, Akram M (2001) The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety. J Neurochem 76:1265\u20131274","journal-title":"J Neurochem"},{"key":"9238_CR75","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.brainres.2004.05.095","volume":"1019","author":"A Przybylkowski","year":"2004","unstructured":"Przybylkowski A, Kurkowska-Jastrzebska I, Joniec I, Ciesielska A, Czlonkowska A, Czlonkowski A (2004) Cyclooxygenases mRNA and protein expression in striata in the experimental mouse model of Parkinson\u2019s disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to mouse. Brain Res 1019:144\u2013151","journal-title":"Brain Res"},{"key":"9238_CR76","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.biochi.2004.10.004","volume":"86","author":"LG Puskas","year":"2004","unstructured":"Puskas LG, Bereczki E, Santha M, Vigh L, Csanadi G, Spener F, Ferdinandy P, Onochy A, Kitajka K (2004) Cholesterol and cholesterol plus DHA diet-induced gene expression and fatty acid changes in mouse eye and brain. Biochimie 86:817\u2013824","journal-title":"Biochimie"},{"key":"9238_CR77","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ejphar.2006.12.032","volume":"560","author":"AB Reksidler","year":"2007","unstructured":"Reksidler AB, Lima MM, Zanata SM, Machado HB, da Cunha C, Andreatini R, Tufik S, Vital MA (2007) The COX-2 inhibitor parecoxib produces neuroprotective effects in MPTP-lesioned rats. Eur J Pharmacol 560:163\u2013175","journal-title":"Eur J Pharmacol"},{"key":"9238_CR78","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.brainres.2007.08.089","volume":"1182","author":"T Sakamoto","year":"2007","unstructured":"Sakamoto T, Cansev M, Wurtman RJ (2007) Oral supplementation with docosahexaenoic acid and uridine-5\u2032-monophosphate increases dendritic spine density in adult gerbil hippocampus. Brain Res 1182:50\u201359","journal-title":"Brain Res"},{"key":"9238_CR79","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/ana.20738","volume":"59","author":"P Samadi","year":"2006","unstructured":"Samadi P, Gregoire L, Rouillard C, Bedard PJ, Di Paolo T, Levesque D (2006) Docosahexaenoic acid reduces levodopa-induced dyskinesias in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys. Ann Neurol 59:282\u2013288","journal-title":"Ann Neurol"},{"key":"9238_CR80","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","volume":"54","author":"AH Schapira","year":"1990","unstructured":"Schapira AH, Cooper JM, Dexter D, Clark JB, Jenner P, Marsden CD (1990) Mitochondrial complex I deficiency in Parkinson\u2019s disease. J Neurochem 54:823\u2013827","journal-title":"J Neurochem"},{"key":"9238_CR81","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s007020100004","volume":"108","author":"N Schmidt","year":"2001","unstructured":"Schmidt N, Ferger B (2001) Neurochemical findings in the MPTP model of Parkinson\u2019s disease. J Neural Transm 108:1263\u20131282","journal-title":"J Neural Transm"},{"key":"9238_CR82","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00441-004-0938-y","volume":"318","author":"A Schober","year":"2004","unstructured":"Schober A (2004) Classic toxin-induced animal models of Parkinson\u2019s disease: 6-OHDA and MPTP. Cell Tissue Res 318:215\u2013224","journal-title":"Cell Tissue Res"},{"key":"9238_CR83","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0166-4328(01)00309-6","volume":"125","author":"M Sedelis","year":"2001","unstructured":"Sedelis M, Schwarting RK, Huston JP (2001) Behavioral phenotyping of the MPTP mouse model of Parkinson\u2019s disease. Behav Brain Res 125:109\u2013125","journal-title":"Behav Brain Res"},{"key":"9238_CR84","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/jn\/119.4.521","volume":"119","author":"AP Simopoulos","year":"1989","unstructured":"Simopoulos AP (1989) Summary of the NATO advanced research workshop on dietary omega 3 and omega 6 fatty acids: biological effects and nutritional essentiality. J Nutr 119:521\u2013528","journal-title":"J Nutr"},{"key":"9238_CR85","first-page":"3465","volume":"57","author":"J Singh","year":"1997","unstructured":"Singh J, Hamid R, Reddy BS (1997) Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis. Cancer Res 57:3465\u20133470","journal-title":"Cancer Res"},{"key":"9238_CR86","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0361-9230(93)90319-7","volume":"32","author":"GM Strain","year":"1993","unstructured":"Strain GM, Tedford BL (1993) Flash and pattern reversal visual evoked potentials in C57BL\/6J and B6CBAF1\/J mice. Brain Res Bull 32:57\u201363","journal-title":"Brain Res Bull"},{"key":"9238_CR87","doi-asserted-by":"crossref","unstructured":"Tanriover G, Seval-Celik Y, Ozsoy O, Akkoyunlu G, Savcioglu F, Hacioglu G, Demir N, Agar A (2010) The effects of docosahexaenoic acid on GDNF and NTN in bilateral rat model of Parkinson`s disease. Folia Histochem Cytobiol 48:434\u2013441","DOI":"10.2478\/v10042-010-0047-6"},{"key":"9238_CR88","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1749-6632.2003.tb07482.x","volume":"991","author":"P Teismann","year":"2003","unstructured":"Teismann P, Vila M, Choi DK, Tieu K, Wu DC, Jackson-Lewis V, Przedborski S (2003) COX-2 and neurodegeneration in Parkinson\u2019s disease. Ann N Y Acad Sci 991:272\u2013277","journal-title":"Ann N Y Acad Sci"},{"key":"9238_CR89","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/molehr\/gah030","volume":"10","author":"K Temma","year":"2004","unstructured":"Temma K, Shimoya K, Zhang Q, Kimura T, Wasada K, Kanzaki T, Azuma C, Koyama M, Murata Y (2004) Effects of 4-hydroxy-2-nonenal, a marker of oxidative stress, on the cyclooxygenase-2 of human placenta in chorioamnionitis. Mol Hum Reprod 10:167\u2013171","journal-title":"Mol Hum Reprod"},{"key":"9238_CR90","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s11745-001-0798-1","volume":"36","author":"R Uauy","year":"2001","unstructured":"Uauy R, Hoffman DR, Peirano P, Birch DG, Birch EE (2001) Essential fatty acids in visual and brain development. Lipids 36:885\u2013895","journal-title":"Lipids"},{"key":"9238_CR91","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1742-2094-3-6","volume":"3","author":"R Vijitruth","year":"2006","unstructured":"Vijitruth R, Liu M, Choi DY, Nguyen XV, Hunter RL, Bing G (2006) Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson\u2019s disease. J Neuroinflamm 3:6","journal-title":"J Neuroinflamm"},{"key":"9238_CR92","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev.genet.39.110304.095751","volume":"39","author":"DC Wallace","year":"2005","unstructured":"Wallace DC (2005) A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 39:359\u2013407","journal-title":"Annu Rev Genet"},{"key":"9238_CR93","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1096\/fj.04-2370com","volume":"19","author":"T Wang","year":"2005","unstructured":"Wang T, Pei Z, Zhang W, Liu B, Langenbach R, Lee C, Wilson B, Reece JM, Miller DS, Hong JS (2005) MPP+-induced COX-2 activation and subsequent dopaminergic neurodegeneration. Faseb J 19:1134\u20131136","journal-title":"Faseb J"},{"key":"9238_CR94","first-page":"327","volume":"40","author":"HS Weisinger","year":"1999","unstructured":"Weisinger HS, Vingrys AJ, Bui BV, Sinclair AJ (1999) Effects of dietary n-3 fatty acid deficiency and repletion in the guinea pig retina. Invest Ophthalmol Vis Sci 40:327\u2013338","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9238_CR95","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.brainres.2006.03.019","volume":"1088","author":"RJ Wurtman","year":"2006","unstructured":"Wurtman RJ, Ulus IH, Cansev M, Watkins CJ, Wang L, Marzloff G (2006) Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally. Brain Res 1088:83\u201392","journal-title":"Brain Res"},{"key":"9238_CR96","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/cr.2007.6","volume":"17","author":"H Yao","year":"2007","unstructured":"Yao H, Tang X, Shao X, Feng L, Wu N, Yao K (2007) Parthenolide protects human lens epithelial cells from oxidative stress-induced apoptosis via inhibition of activation of caspase-3 and caspase-9. Cell Res 17:565\u2013571","journal-title":"Cell Res"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-011-9238-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-011-9238-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-011-9238-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T20:38:17Z","timestamp":1559939897000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-011-9238-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,14]]},"references-count":96,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["9238"],"URL":"https:\/\/doi.org\/10.1007\/s12640-011-9238-y","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,14]]}}}